Florida Becomes The First State To Scan For Genetic Diseases In All Newborns
(Posted on Thursday, October 16, 2025)
Many babies enter the world with silent metabolic or genetic conditions. Today, standard newborn screening can check for only a handful of these diseases—often just a few dozen, depending on where you live. However, recent breakthroughs in genetic analysis now make it possible to scan for hundreds more, with whole-genome sequencing expanding this number by as much as a third or more. Not only does this technology spot more risks, but it also enables life-saving interventions that can change the course of a child’s future.
Despite these advances, whole genome sequencing, and with it the promise of early, life-altering therapies, still isn’t a routine part of care for most newborns. As outlined in the book I co-authored, Destiny’s Child No Longer: Rewriting Genetic Fate, this gap between what is possible and what is practiced persists across much of the world.
The good news is that change is no longer theoretical. A pioneering program in Florida now puts these advances into practice, offering comprehensive newborn genome sequencing as part of standard care. This Florida program, shaped by collaborative leadership across government, medicine and research, makes genetic analysis and early intervention a reality—not just an aspiration.
Evidence supporting this approach continues to grow every year. In Denmark, decades of experience with nationwide heel-stick blood tests, now routinely enhanced with advanced genetic methods, show how early screening can save lives and reduce suffering. Global studies, from recent trials in Australia to major new NHS programs in the U.K., confirm that these methods reliably identify conditions that would otherwise remain undetected, enabling doctors to take action before any symptoms appear.
Florida’s new initiative may be only one step, but it signals a larger shift. As more states and countries join the movement, there is hope that universal, equitable newborn genomic screening will soon become the standard of care, ensuring that every infant, regardless of their place of birth, receives the best possible start.
The Sunshine Genetics Act: A New Model for Care
Enacted in 2025, the Sunshine Genetics Act makes Florida the first state to offer universal whole-genome sequencing as a standard part of newborn care. Championed by State Representative Adam Anderson and supported by Florida State University’s Institute for Pediatric Rare Diseases and other partners, the Act authorizes sequencing for up to 100,000 newborns. This removes barriers to early diagnosis and timely treatment.
The initiative unites institutions such as Florida State University and GeneDx to translate years of genomic research into real-world health care. Together, they are establishing Florida as the first state to fully integrate genomic screening into routine pediatric care—not as a luxury, but as a public health imperative. Legislative leadership, scientific vision and institutional collaboration have created a framework for proactive, equitable health care that could become a blueprint for the nation.
Read Dr. Haseltine's latest piece with
